-
Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Sep 9, 2025, 16:22 PM -
Harmonization of Drug Policy and Regulation Across Europe: A Comparison Between the European Medicines Agency and the European HTA Regulation
Sep 9, 2025, 16:22 PM -
Evolution of Utilization and Costs of Long-Acting Injectable Antipsychotics (LAIs) in Outpatient Care at Lisbon Psychiatric Hospital (March-May 2022 vs. 2025)
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Different Payment Models on the Cost-Effectiveness and Budget Impact of Cell and Gene Therapies: Eladocagene Exuparvovec As a Case Study
Sep 9, 2025, 16:22 PM -
Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan
Sep 9, 2025, 16:22 PM -
Are We SEEing It Yet? The Use of Structured Expert Elicitation Protocols for Decision Making
Sep 9, 2025, 16:22 PM -
Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan
Sep 9, 2025, 16:22 PM -
Towards Quantifying the Impact of Hypofractionation vs. Standard Radiotherapy Treatment Regimens for Cancer on Costs Workflow and the Environment
Sep 9, 2025, 16:22 PM -
The Role of Lifestyle in the Development of Fertility Issues
Sep 9, 2025, 16:22 PM -
Patient Access Delays for Subsequent Indications of Multi-indication Treatments: An Assessment of Health Technology Assessment Decision Making
Sep 9, 2025, 16:22 PM -
Costs and Health Outcomes of Meek Skin Micrografting vs. Mesh Skin Grafting in Adult Patients With Deep Partial Thickness and/or Full-Thickness Small (Burn) Wounds
Sep 9, 2025, 16:22 PM -
The Clinical, Humanistic and Economic Burden of the Management of Patients With Recurrent Malignant Ascites in the UK and Europe
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Secukinumab for Moderate to Severe Hidradenitis Suppurativa in Portugal
Sep 9, 2025, 16:22 PM -
COPD-Asthma Overlap in Brazilian Private Healthcare: Clinical Profiles and Outcomes from a Real-World Analysis
Sep 9, 2025, 16:22 PM -
Persistence to Basal Insulin and Economic Outcomes Among Patients With Type 2 Diabetes: A Retrospective Analysis Using Electronic Health Records in England
Sep 9, 2025, 16:22 PM -
Burden of Disease in Hereditary Transthyretin Amyloidosis With Polyneuropathy in Spain
Sep 9, 2025, 16:22 PM -
Complement C5 Inhibitor (Anti-C5) and Neonatal Fc Receptor Antagonist Anti-FcRn in Myasthenia Gravis at University Public Hospitals of Paris, France (AP-HP): What Is the Market Share of These New Treatments?
Sep 9, 2025, 16:22 PM -
Market Access 2030: AI-Driven Dossier Transformation and Therapeutic Value Communication Across Global Health Systems
Sep 9, 2025, 16:22 PM
